Replies to post #63760 on Ayala Pharmaceuticals Inc (fka ADXS)

[scottmiyadi]

Not to mention that PETX has this on their back burner and even if inclined isn't strong enough financially to push aggressively forward.

[Chemist823]

We need to develop the human indications, the pet market isn't worth that much. 99% of pet owners either can't afford or wouldn't be willing to pay for surgery and treatment so there is only so much market. They still owe adxs 30 million on approval and royalties. Considering they just sold 10 million shares for 20 mill that $30 million possibly coming next year looks pretty good.